The enterprise risk management has been a recurring theme on the agenda of organizations. The competition is increasingly established among the supply chains of organizations. In this sense, it is ...appropriate that this research aims to analyze the enterprise risk management in the supply chain of Brazilian companies. As a conceptual framework, it has been adopted three theoretical pillars, namely, New Institutional Economics, Supply Chain and Enterprise Risk Management. The research was divided into three stages: interviews with experts on the subject, survey with managers of large Brazilian companies, and validation of the proposals from the analysis of the results with the same experts. The analysis of results was established mainly by the use of multivariate statistical techniques such as correspondence analysis, factor analysis, cluster analysis and multinomial logistic regression. As a result of the study, it was presented a proposal of model for an enterprise risk analysis, as well as a proposal of model for analysis of the level of maturity in enterprise risk management in the supply chain of large Brazilian companies.
•Enterprise risk management in the supply chain of large Brazilian companies.•Enterprise risk analysis model.•Maturity model for enterprise risk management in the supply chain.
This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by ...PRMS (www.prms.com), a manager of medical professional liability insurance programs with services that include risk management consultation and other resources offered to health care providers to help improve patient outcomes and reduce professional liability risk. The answers published in this column represent those of only one risk management consulting company. Other risk management consulting companies or insurance carriers might provide different advice, and readers should take this into consideration. The information in this column does not constitute legal advice. For legal advice, contact your personal attorney. Note: The information and recommendations in this article are applicable to physicians and other health care professionals so "clinician" is used to indicate all treatment team members.
This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by ...PRMS (www.prms.com), a manager of medical professional liability insurance programs with services that include risk management consultation and other resources offered to health care providers to help improve patient outcomes and reduce professional liability risk. The answers published in this column represent those of only one risk management consulting company. Other risk management consulting companies or insurance carriers might provide different advice, and readers should take this into consideration. The information in this column does not constitute legal advice. For legal advice, contact your personal attorney. Note: The information and recommendations in this article are applicable to physicians and other health care professionals so "clinician" is used to indicate all treatment team members.
This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by ...PRMS (www.prms.com), a manager of medical professional liability insurance programs with services that include risk management consultation and other resources offered to health care providers to help improve patient outcomes and reduce professional liability risk. The answers published in this column represent those of only one risk management consulting company. Other risk management consulting companies or insurance carriers might provide different advice, and readers should take this into consideration. The information in this column does not constitute legal advice. For legal advice, contact your personal attorney. Note: The information and recommendations in this article are applicable to physicians and other health care professionals so “clinician” is used to indicate all treatment team members.
The field of advanced therapies has witnessed unprecedented growth, presenting unique challenges in quality management. We explore the multifaceted aspects of ensuring quality throughout the ...lifecycle, from rapid development through the crucial transition to full-scale cGMP compliance using phase-appropriate risk management.
The rapid pace of development in advanced therapies introduces a challenge in maintaining robust quality standards. Balancing speed and quality requires a dynamic approach that addresses the intricacies of research and development while adhering to stringent regulatory requirements. This demands a proactive risk management system that anticipates and mitigates risks associated with accelerated timelines. Strategies for material qualification, supplier validation, and risk mitigation must be implemented to ensure a seamless transition from development to manufacturing.
Manufacturing space poses another challenge, particularly as therapies progress towards commercialization. Scaling up production necessitates careful consideration of facility design, equipment validation, and process scalability. Maintaining product consistency across different manufacturing scales requires an integrated quality management approach that aligns with regulatory expectations.
The ultimate goal of commercialization is achieving full-scale cGMP compliance, and marks a pivotal phase which demands adherence to rigorous regulatory standards. Developing and implementing robust quality control measures, process validation protocols, and comprehensive documentation are imperative to ensure product safety, efficacy, and consistency. Leveraging risk management to inform decision making at early stages of the lifecycle is an opportunity for efficiency and streamlining the path to commercialization and operational success.
The solution to these challenges lies in the proactive implementation of risk management at all levels of the organization. This includes embedding risk assessments in the facility design, material selection, process controls, release requirements, as well as change management. A comprehensive and adaptable risk management framework enhances the ability to identify, assess, and mitigate potential risks, ensuring the sustained quality and compliance of advanced therapies throughout their lifecycle.
Canada is a country in the midst of a flood management policy transition that is shifting part of the flood damage burden from the state to homeowners. This transition—as well as the large financial ...losses resulting from flooding—have created a window of opportunity for Canada to implement strategies that increase property owners' capacity to avoid and absorb the financial and physical risks associated with flooding. This work presents foundational research into the extent to which Canadians' flood experience, perceptions of flood risks and socio-demographics shape their intentions and adoption of property level flood protection (PLFP). A bilingual, national survey was deployed in Spring 2016 and was completed by 2300 respondents across all 10 Canadian provinces. The survey was developed using assumptions in existing literature on flood risk behaviours and the determinants of flood risk management in similar jurisdictions. The paper argues that property owners are not willing to accept greater responsibility for flood risk as envisioned by recent policy changes. This finding is consistent with other OECD jurisdictions, where flood risk engagement strategies have been developed that could be replicated in Canada to encourage risk-sharing behaviour.
Purpose
The purpose of this paper is to identify and analyse collaborative risk management (CRM) literature to establish its current position in supply chain risk management (SCRM) and propose an ...agenda for future research.
Design/methodology/approach
A systematic literature review of 101 peer-reviewed articles over a 21-year period was employed to analyse literature and synthesise findings to clarify terminology, definitions, CRM capabilities, and underlying theory.
Findings
CRM as a field of research is in its infancy and suffers from imprecise definitions, fragmented application of capabilities, and diverse theoretical foundations. The term CRM is identified as a more representative description of relational risk management arrangements. Six capabilities relevant to CRM are identified: risk information sharing, standardisation of procedures, joint decision making, risk and benefit sharing, process integration, and collaborative performance systems.
Originality/value
The paper provides a new definition for CRM; proposes a holistic approach in extending collaboration to SCRM; identifies a new capability; and provides a range of theories to broaden the theoretical scope for future research on CRM.
PDF
